PT  - JOURNAL ARTICLE
AU  - Zhang, Yeqing
AU  - Patil, Priyanka
AU  - Lakhanpaul, Monica
AU  - Heys, Michelle
AU  - Chakraborty, Subarna
AU  - Dwardzweska, Joanna
AU  - Llewellyn, Clare H.
AU  - Webb-Martin, Kelley
AU  - Irish, Carol
AU  - Archibong, Mfon
AU  - Gilmour, Jenny
AU  - Kalungi, Phoebe
AU  - Skordis, Prof Jolene
AU  - Manikam, Logan
AU  - Batura, Neha
AU - the NEON Steering Team
TI  - Economic Evaluation: Costing participatory learning and action cycles with women’s groups to improve feeding, care and dental hygiene for South Asian infants in London
AID  - 10.1101/2024.03.09.24304022
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.09.24304022
4099  - http://medrxiv.org/content/early/2024/03/18/2024.03.09.24304022.short
4100  - http://medrxiv.org/content/early/2024/03/18/2024.03.09.24304022.full
AB  - Background The Nurture Early for Optimal Nutrition (NEON) programme was designed to promote equitable early childhood development by educating mothers of South Asian origin in east London on optimal feeding, care, and dental hygiene practices. This study conducts a cost analysis of the NEON programme and evaluates its financial sustainability.Methods We conducted an economic costing from the provider perspective and followed a stepdown procedure to identify all costs incurred from December 2019, the initiation of the trial, to May 2023, the completion of final evaluation and dissemination. Costs associated with start-up, implementation, and monitoring and evaluation activities are differentiated. Affordability analysis was conducted with respect to the budget of the local authorities.Results The total cost of NEON design and delivery in Newham and Towe Hamlets was £75,992 ($INT 114,445), with 45% for staff salaries, 50% for material, and 5% for capital investment. The start-up stage cost 57% while the implementation stage cost 43%. The average cost per mother participating in the programme was £409($INT 615). The total cost of trial delivery in Newham accounted for around 0.053% of the borough’s annual child development expenditure, while the total trial cost in Tower Hamlets was equivalent to 0.003% of its’ spending on children’s development.Conclusion The delivery of NEON is largely within local authorities’ budget for childhood development. The unit cost is expected to decrease when sharing costs are spread across more participants and implementing systems are validated and well developed.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIRAS-ID-296259 (ISRCTN10234623)Funding StatementLogan Manikam & Priyanka Patil were funded via a National Institute for Health Research (NIHR) Advanced Fellowship (Ref: NIHR300020) to undertake the Pilot Feasibility Cluster Randomised Controlled Trial of the NEON programme in East London.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has obtained ethical approval from UCL Research Ethics Committee [Ethics ID 17269/001], Sponsor reference number: 142600, Funding Reference: NIHR300020 and IRAS number: 296259, Ref: 21/SW/0142. Study protocols and relevant documents were reviewed by UCL Research Ethics Committee, NHS Health Research Authority (HRA) and study partners involved in establishing data sharing agreement for linking participants' routine data (Tower Hamlets GP Care Group, London Borough of Newham Council).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors